Atlas Trials

A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma

Clinical trial NCT01730222 · COMPLETED

Trial details

NCT number
NCT01730222
Sponsor
IRCCS San Raffaele
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2012-11-01
Primary completion
2017-02-01
Enrollment
137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.